BioPhorum Connect – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

BioPhorum Connect

BioPhorum

Sciences

Fréquence : 1 épisode/36j. Total Éps: 51

BioPhorum Connect is a podcast series that talks to thought leaders and subject matter experts about the latest trends and challenges facing the biopharmaceutical industry. From digitization, knowledge management, raw materials, supply chain, sustainability, and everything in between, listen now and get the low down.

Lire plusRéduire

Site

RSS

Apple

Données mises à jour le 04/07/2026

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://events.teams.microsoft.com/event/a813017d-0ed9-4b6c-a548-3ac74437c9f6@0d7390ce-09f9-466c-be3d-b93e030fdce2
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 38%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

How better material decisions shape drug delivery devices

mercredi 29 avril 2026 • Durée 33:54

In this episode of BioPhorum Connect, Loic Bishop is joined by Lucas Pianagonda, a materials science expert in sustainable plastics, to explore how sustainability can be embedded into the design and material selection of drug delivery devices. The discussion covers key pressures driving change in biopharma, practical challenges in redesigning established devices, and where meaningful sustainability gains can realistically be made—spanning eco-design, material trade-offs, lifecycle assessment, and emerging trends such as mass balance plastics and AI-enabled material selection.

Lire plusRéduire

Advancing transformation with the QC lab of the future manifesto 2.0

lundi 2 février 2026 • Durée 34:27

In this BioPhorum Connect episode, Charlotte Scutt, Global Change Facilitator at BioPhorum, hosts a strategic conversation with senior authors Laura Mahoney (Pfizer) and Steven Muller (Bristol Myers Squibb) to explore the collaborative development and purpose of the 'Manifesto: Digital technology-based capabilities for the quality control (QC) lab of the future 2.0', published in July 2025.

Rather than offering a fixed solution, the manifesto provides a structured vision and practical considerations for QC labs navigating digital transformation. The speakers reflect on industry-wide challenges such as fragmented systems, manual workflows, and limited automation, and how the manifesto—now aligned with the 'Digital plant maturity model (DPMM 3.0)'—helps organizations build strong data foundations, foster collaboration and make informed decisions to advance digital maturity.

Listeners are encouraged to use the manifesto as a strategic blueprint, share it across teams and join the ongoing BioPhorum conversations shaping the future of QC labs.

Lire plusRéduire

From the surface up: Navigating biocompatibility challenges

mercredi 21 janvier 2026 • Durée 39:54

In this episode of BioPhorum Connect, Loic Bishop sits down with returning guest Soumen Das, Delivery Systems Qualification Lead at Takeda, to explore the evolving world of biocompatibility in drug-device combination products. Soumen shares his journey from academic research in chemistry and biochemistry to leading biocompatibility strategies for global pharmaceutical delivery systems.

The conversation dives deep into:

The shift from checklist-based testing to risk-based approaches under ISO 10993-1 and its connection to ISO 14971.
Challenges in global regulatory alignment, including differing requirements across FDA, EU, PMDA, and China.
The role of platform technologies in accelerating drug-device development and leveraging existing safety data.
Supplier engagement and material risk assessment—why early involvement of biocompatibility experts matters.
Training and cross-functional awareness—building company-wide understanding to flag changes that affect biocompatibility.
Whether you’re a biocompatibility professional, regulatory strategist, or simply curious about how patient safety is ensured in complex delivery systems, this episode offers practical insights and forward-looking perspectives.

Lire plusRéduire

Designing drug delivery devices: Prioritizing simplicity, empathy and real patient needs

mardi 9 décembre 2025 • Durée 29:51

Designing Drug Delivery Devices: Prioritizing Simplicity, Empathy, and Real Patient Needs

Description / Show notes: Andy discusses the importance of patient-centered design in drug delivery devices, emphasizing that simplicity, reliability, and empathy should guide innovation rather than adding unnecessary features. Andy shares insights from his experience in human factors and medical design, highlighting the challenges patients face with complex therapies and the need to design devices that fit seamlessly into their lives. The conversation covers the pitfalls of overcomplicated devices, the myth of patient engagement, and the tension between regulatory requirements and true user needs, with examples illustrating how usability can be compromised by commercial or regulatory pressures.

Patient-Centered Design: Understanding real patient needs and lifestyles is crucial, and devices should be designed to minimize cognitive load and fit into daily routines.
Simplicity Over Complexity: Reliability and simplicity are more valuable to patients than flashy features, especially for those managing multiple therapies.
Challenges with Existing Therapies: Older, complex drug reconstitution processes persist due to regulatory grandfathering, leading to frequent user errors.
Engagement Myth: Debunking the idea that patients are excited about therapies, explaining that adherence is more about convenience than engagement.
Regulatory vs. User Needs: The discussion highlights how some device features are added to meet regulatory or commercial goals, not actual patient benefit, sometimes increasing complexity without improving usability.

Lire plusRéduire

From jet engines to heartbeats: Engineering the future of healthcare

vendredi 17 octobre 2025 • Durée 01:07:47

In this episode of BioPhorum Connect, host Loic Bishop speaks with Dr. Steven Levine, Senior Director of Life Sciences and Healthcare at Dassault Systèmes and Executive Director of the Living Heart Project. They explore how engineering principles and digital twin technology are reshaping the future of medicine—from personalised treatment planning to regulatory-grade simulations.

Steven shares his personal journey, including how his daughter's congenital heart condition and a brain tumour has inspired him to pioneer a new approach to medical modelling. Learn how the Living Heart Project grew from a bold idea into a global collaboration involving over 165 organisations, and how it’s now influencing how we run clinical trials, regulatory processes, and the development of digital organs.

Topics include:

The origins and impact of the Living Heart Project
Building a fully functioning digital heart
Collaboration with the FDA and global regulators
The future of digital twins in drug development and personalised care

Lire plusRéduire

From designing to depending: A drug delivery journey

jeudi 16 octobre 2025 • Durée 44:52

Rick Wedge shares his personal and professional journey from developing medical devices to becoming a patient dependent on diabetes technology, following a total pancreatectomy and diagnosis of Type 3C diabetes.

The discussion covers the challenges of managing diabetes, the importance of wearables and continuous glucose monitoring, and the impact of technology on quality of life.

Rick reflects on how his experience as a patient has deepened his perspective on risk management and device design, emphasizing the real-world implications for patients.

The episode also explores future improvements for diabetes devices and the value of patient-centric innovation.

Lire plusRéduire

Implementing AI systems

jeudi 24 juillet 2025 • Durée 25:48

This AI-generated conversation explores the challenges of implementing AI in pharma accurately, reliably and safely, particularly given the stringent requirements of good practice (GxP) regulations and the need to enhance trust among stakeholders, including regulatory authorities, healthcare professionals, and patients.

It is based on the BioPhorum publication Implementing AI systems in regulated pharma environments and key takeaways include:

The whole AI lifecycle needs to be managed
It's a risk-based approach with risk management throughout
Setting clear objectives and scope creates the essential focus for success
For reliable AI, data needs to be really well managed
Algorithm selection and model design needs discipline to create assurance
Deployment is about thinking of the whole system, which could include many AIs
Data drifts, so ongoing monitoring and evaluation is essential
Change control includes a much bigger challenge of version management

You can also watch a 90-min webinar replay by nine of the (real-life) authors who illustrate each point from their experience.

Lire plusRéduire

Minimizing the impact of stability testing on low-yield biopharmaceuticals

mardi 15 juillet 2025 • Durée 06:40

In this episode of BioPhorum connect, we explore the newly published ASTM International standard guide 'Guide for Minimizing the impact of stability testing on batch yield of low yield biopharmaceutical products.'

This guide, authored by BioPhorum members, builds on a foundational BioPhorum publication developed through collaboration among 12 companies in the Advanced Therapy Medicinal Products (ATMP) space, particularly focused on gene therapies.

Simon Walker, Global Change Facilitator at BioPhorum, is joined by two key contributors to both the original BioPhorum deliverable and the ASTM guide:

Gael Debauve, Head of Gene Therapy Analytical Sciences at UCB
Madison Lee, Associate Director of CMC Program Management at Regeneron

Together, they discuss:

Why minimizing the impact of stability testing is critical for low-yield products
How the ASTM International guide expands the scope beyond gene therapies
The value of using a mock gene therapy product to quantify potential savings
Who in the industry will benefit most from this guidance
The collaborative advantage of working through BioPhorum

Whether you're in QC, QA, regulatory affairs, or CMC leadership, this episode offers valuable insights into improving efficiency and conserving product in early-stage development.

Lire plusRéduire

Cybersecurity in biomanufacturing: Insights from industry practitioners

mardi 1 avril 2025 • Durée 37:11

Join us for an insightful episode of the BioPhorum podcast, where we delve into the critical topic of cybersecurity in the biomanufacturing industry, which is now woven into the overall vision for digital maturity expressed in the Digital Plant Maturity Model. Hosted by Tim Horton, this episode features expert guests Anderson Goebel from Merck and Tom House from Rockwell Automation, who share their practical experiences and strategies for enhancing cybersecurity in their organizations.

Key topics discussed include:

The importance of IT and OT convergence for digital maturity and cybersecurity.
Practical steps for implementing cybersecurity frameworks and achieving consistency across organizations.
The impact of regulatory changes and validation challenges on cybersecurity practices.
The role of tabletop exercises in improving collaboration and risk management.

Don't miss this opportunity to gain valuable insights and learn from industry leaders.

Check out the resources mentioned in the podcast:

Lire plusRéduire

Managing data as a product

vendredi 10 janvier 2025 • Durée 14:35

Our AI-generated podcast explores the transformative concept of managing data as a product, and discusses how adopting a data product mindset can revolutionize digital transformation in the pharmaceutical industry.

Key takeaways include:

Understanding the importance of clear data ownership roles
Exploring different data architecture strategies like data mesh and data fabric
Realizing that a data product is more than just a dataset and what that means for ownership roles
Visualizing the lifecycle of a data product and the responsibilities involved.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à BioPhorum Connect. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

Il n'y a pas de contenu associé à ce podcast.

À propos Méthodologie Contact Me soutenir Politique de confidentialité Mentions légales

BioPhorum Connect – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other16

Financial Times1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Other16

Financial Times1

Apple Podcasts

Spotify